---
title: "《業績》南洋集團中期純利 2,753 萬元  虧轉盈"
description: "南洋集團公佈 6 月止六個月中期業績，收入與其他收益 1.69 億元，按年增加 17.5%。錄得純利 2,753 萬元，相較去年同期虧損 4,374 萬元，虧轉盈；每股盈利 81 仙。不派息。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/254322857.md"
published_at: "2025-08-24T12:10:14.000Z"
---

# 《業績》南洋集團中期純利 2,753 萬元  虧轉盈

> 南洋集團公佈 6 月止六個月中期業績，收入與其他收益 1.69 億元，按年增加 17.5%。錄得純利 2,753 萬元，相較去年同期虧損 4,374 萬元，虧轉盈；每股盈利 81 仙。不派息。

南洋集團 (00212.HK) 公佈 6 月止六個月中期業績，收入與其他收益 1.69 億元，按年增加 17.5%。錄得純利 2,753 萬元，相較去年同期虧損 4,374 萬元，虧轉盈；每股盈利 81 仙。不派息。

### Related Stocks

- [00212.HK - 南洋集團](https://longbridge.com/zh-HK/quote/00212.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Standard Chartered PLC (OTCMKTS:SCBFF) Sees Significant Growth in Short Interest | Standard Chartered PLC (OTCMKTS:SCBFF) experienced a significant increase in short interest, rising 21.1% to 210,583 sha | [Link](https://longbridge.com/zh-HK/news/276119010.md) |
| CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | [Link](https://longbridge.com/zh-HK/news/276035104.md) |
| Will China Literature Turn The Page? | China Literature Ltd. expects a net loss of up to 850 million yuan for last year, primarily due to a 1.8 billion yuan go | [Link](https://longbridge.com/zh-HK/news/276113491.md) |
| Beijing Haizhi Technology Announces Final Offer Price | Beijing Haizhi Technology Group Co Ltd:FINAL OFFER PRICE HK$27.06 PER H SHARE UNDER GLOBAL OFFERING | [Link](https://longbridge.com/zh-HK/news/275780031.md) |
| Huatai Securities Keeps Their Buy Rating on China Literature (CHLLF) | In a report released on February 13, from Huatai Securities maintained a Buy rating on China Literature, with a price ta | [Link](https://longbridge.com/zh-HK/news/275996484.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。